Kenneth R. Fisher - 01 Feb 2023 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)

Role: Chief Financial Officer
Signature: /s/ Kenneth Fisher
Issuer symbol: BJDX
Transactions as of: 01 Feb 2023
Net transactions value: +$32,201
Form type: 4
Filing time: 13 Feb 2023, 16:36:02 UTC
Previous filing: 07 Sep 2022
Next filing: 10 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BJDX	Common Stock	Award	$49,500	+112,500	+281%	$0.4400	152,500	01 Feb 2023	Direct
transaction	BJDX	Common Stock	Tax liability	$17,299	-39,316	-26%	$0.4400	113,184	01 Feb 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

(1) These shares of restricted stock vest at 100% on the grant date. (2) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock awards. This sale was made to satisfy tax withholding obligations by a sell to cover transaction and does not represent a discretionary trade by the reporting person.